nach oben

Endocrine

Erschienen in:

19.11.2021 | Original Article

A novel targeted approach to delineate a role for estrogen receptor-β in ameliorating murine mammary tumor-associated neuroinflammation

verfasst von: Corena V. Grant, Kathryn L. G. Russart, Leah M. Pyter

Erschienen in: Endocrine | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Circulating estrogens in breast cancer patients and survivors are often extremely low due to menopause and estrogen-reducing cancer treatments. Simultaneously, circulating inflammatory markers, and inflammatory proteins in brains of rodent tumor models, can be elevated and correlate with debilitating neurological and psychological comorbidities. Because estrogen has anti-inflammatory properties in the brain, we hypothesized that mammary tumor-induced neuroinflammation is driven, in part, by reduced brain estrogen signaling.

Methods

An ovariectomized mouse model of postmenopausal breast cancer utilizing the ERα-positive 67NR mammary tumor cell line was used for these experiments. A novel, orally bioavailable, and brain penetrant ERβ agonist was administered daily via oral gavage. Following treatment, estrogen-responsive genes were measured in brain regions. Central and circulating inflammatory markers were measured via RT-qPCR and a multiplex cytokine array, respectively.

Results

We present novel findings that peripheral mammary tumors alter estrogen signaling genes including receptors and aromatase in the hypothalamus, hippocampus, and frontal cortex. Mammary tumors induced peripheral and central inflammation, however, pharmacological ERβ activation was not sufficient to reduce this inflammation.

Conclusions

Data presented here suggest that compensating for low circulating estrogen with ERβ brain activation is not sufficient to attenuate mammary tumor-induced neuroinflammation, and is therefore not a likely candidate for the treatment of behavioral symptoms in patients. The novel finding that mammary tumors alter estrogen signaling-related genes is a clinically relevant advancement to the understanding of how peripheral tumor biology modulates neurobiology. This is necessary to predict and prevent behavioral comorbidities (e.g., cognitive impairment) prevalent in cancer patients and survivors.

Nur mit Berechtigung zugänglich

R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2020. CA Cancer J. Clin. (2020). https://doi.org/10.3322/caac.21590

L.M. Hess, K.C. Insel, Chemotherapy-related change in cognitive function: a conceptual model. Oncol. Nurs. Forum (2007). https://doi.org/10.1188/07.ONF.981-994

J.R. Satin, W. Linden, M.J. Phillips, Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer (2009). https://doi.org/10.1002/cncr.24561

M.C. Janelsins, K.M. Mustian, O.G. Palesh, S.G. Mohile, L.J. Peppone, L.K. Sprod, C.E. Heckler, J.A. Roscoe, A.W. Katz, J.P. Williams, G.R. Morrow, Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support. Care Cancer (2012). https://doi.org/10.1007/s00520-011-1158-0

M. Seretny, G.L. Currie, E.S. Sena, S. Ramnarine, R. Grant, MacLeod M.R., L.A. Colvin, M. Fallon, Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain (2014). https://doi.org/10.1016/j.pain.2014.09.020

A. Schrepf, S.K. Lutgendorf, L.M. Pyter, Pre-treatment effects of peripheral tumors on brain and behavior: Neuroinflammatory mechanisms in humans and rodents. Brain Behav. Immun. (2015). https://doi.org/10.1016/j.bbi.2015.04.010

R.M. Barrientos, L.D. Strehle, A.A. Lahoud, L.M. Pyter, Mammary tumors suppress aging-induced neuroinflammation in female Balb/c mice. Compr. Psychoneuroendocrinol. (2020). https://doi.org/10.1016/j.cpnec.2020.100002

L.M. Pyter, V. Pineros, J.A. Galang, M.K. McClintock, B.J. Prendergast, Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation. Proc. Natl. Acad. Sci. (2009). https://doi.org/10.1073/pnas.0811949106

N.L. Sparkman, J.B. Buchanan, J.R.R. Heyen, J. Chen, J.L. Beverly, R.W. Johnson, Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J. Neurosci. (2006). https://doi.org/10.1523/JNEUROSCI.3376-06.2006

10.

D.M. Norden, J.P. Godbout, Review: Microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol. Appl. Neurobiol. (2013). https://doi.org/10.1111/j.1365-2990.2012.01306.x

11.

L. Pietranera, M.J. Bellini, M.A. Arévalo, R. Goya, M.E. Brocca, L.M. Garcia-Segura, A.F. De Nicola, Increased aromatase expression in the hippocampus of spontaneously hypertensive rats: effects of estradiol administration. Neuroscience (2011). https://doi.org/10.1016/j.neuroscience.2010.11.044

12.

M.I. Rossberg, S.J. Murphy, R.J. Traystman, P.D. Hurn, LY353391.HCl, a Selective Estrogen Receptor Modulator and Experimental Stroke. Stroke (2000). https://doi.org/10.1161/01.str.31.12.3041

13.

H.V.O. Carswell, A.F. Dominiczak, L.M. Garcia-Segura, N. Harada, J.B. Hutchinson, I.M. Macrae, Brain aromatase expression after experimental stroke: topography and time course. J. Steroid Biochem. Mol. Biol. (2005). https://doi.org/10.1016/j.jsbmb.2005.02.016

14.

C.E. DeSantis, J. Ma, M.M. Gaudet, L.A. Newman, K.D. Miller, A.G. Sauer, A. Jemal, R.L. Siegel, Breast cancer statistics, 2019. CA Cancer J. Clin. (2019). https://doi.org/10.3322/caac.21583

15.

X. Qian, Z. Li, G. Ruan, C. Tu, W. Ding, Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials. Breast Cancer Res. Treat. (2020). https://doi.org/10.1007/s10549-019-05464-w

16.

H.K. Patel, T. Bihani, Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharmacol. Ther. (2018). https://doi.org/10.1016/J.PHARMTHERA.2017.12.012

17.

W.M. Pardridge, L.J. Mietus, Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J. Clin. Investig. (1979). https://doi.org/10.1172/JCI109433

18.

M. Bixo, T. Bäckström, B. Winblad, A. Andersson, Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J. Steroid Biochem. Mol. Biol. (1995). https://doi.org/10.1016/0960-0760(95)00179-4

19.

C.M. Brown, T.A. Mulcahey, N.C. Filipek, P.M. Wise, Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta. Endocrinology (2010). https://doi.org/10.1210/en.2010-0371

20.

E. Vegeto, V. Benedusi, A. Maggi, Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases. Front. Neuroendocrinol. (2008). https://doi.org/10.1016/j.yfrne.2008.04.001

21.

D.H. Cribbs, N.C. Berchtold, V. Perreau, P.D. Coleman, J. Rogers, A.J. Tenner, C.W. Cotman, Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J. Neuroinflammation (2012). https://doi.org/10.1186/1742-2094-9-179

22.

M. Sárvári, E. Hrabovszky, I. Kalló, N. Solymosi, I. Likό, N. Berchtold, C. Cotman, Z. Liposits, Menopause leads to elevated expression of macrophage-associated genes in the aging frontal cortex: rat and human studies identify strikingly similar changes. J. Neuroinflammation. (2012). https://doi.org/10.1186/1742-2094-9-264

23.

F. Yin, J. Yao, H. Sancheti, T. Feng, R.C. Melcangi, T.E. Morgan, C.E. Finch, C.J. Pike, W.J. Mack, E. Candenas, R.D. Brinton, The perimenopausal aging transition in the female rat brain: Decline in bioenergetic systems and synaptic plasticity. Neurobiol. Aging (2015). https://doi.org/10.1016/j.neurobiolaging.2015.03.013

24.

I. Paterni, C. Granchi, J.A. Katzenellenbogen, F. Minutolo, Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential. Steroids (2014). https://doi.org/10.1016/j.steroids.2014.06.012

25.

L.-A. Haldosén, C. Zhao, K. Dahlman-Wright, Estrogen receptor beta in breast cancer. Mol. Cell. Endocrinol. (2014). https://doi.org/10.1016/j.mce.2013.08.005

26.

B.S. McEwen, S.E. Alves, Estrogen Actions in the Central Nervous System. Endocr. Rev. (1999). https://doi.org/10.1210/edrv.20.3.0365

27.

S.L. Petersen, E.N. Ottem, C.D. Carpenter, Direct and Indirect Regulation of Gonadotropin-Releasing Hormone Neurons by Estradiol. Biol. Reprod. (2003). https://doi.org/10.1095/biolreprod.103.019745

28.

S.X. Simonian, D.P. Spratt, A.E. Herbison, Identification and characterization of estrogen receptor α‐containing neurons projecting to the vicinity of the gonadotropin‐releasing hormone perikarya in the rostral preoptic area of the rat. J. Comp. Neurol. (1999). https://doi.org/10.1002/(SICI)1096-9861(19990823)411:2<346::AID-CNE13>3.0.CO;2-S

29.

B.D. Soper, R.F. Weick, Hypothalamic and extrahypothalamic mediation of pulsatile discharges of luteinizing hormone in the ovariectomized rat. Endocrinology (1980). https://doi.org/10.1210/endo-106-1-348

30.

R. Diaz Brinton, Minireview: Translational Animal Models of Human Menopause: Challenges and Emerging Opportunities. Endocrinology (2012). https://doi.org/10.1210/en.2012-1340

31.

J.T. Smith, M.J. Cunningham, E.F. Rissman, D.K. Clifton, R.A. Steiner, Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology (2005). https://doi.org/10.1210/en.2005-0488

32.

E. Hrabovszky, P.J. Shughrue, I. Merchenthaler, T. Hajszán, C.D. Carpenter, Z. Liposits, S.L. Petersen, Detection of estrogen receptor-β messenger ribonucleic acid and 125I-estrogen binding sites in luteinizing hormone-releasing hormone neurons of the rat brain. Endocrinology (2000). https://doi.org/10.1210/endo.141.9.7788

33.

D. Sedlák, T.A. Wilson, W. Tjarks, H.S. Radomska, H. Wang, J. Narayana Kolla, Z.J. Leśnikowski, A. Špičáková, T. Ali, T. Ishita, L. Harinantenaina Rakotondraibe, S. Vibhute, D. Wang, P. Anzenbacher, C. Bennett, P. Barkunet, C.C. Coss, Structure–Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists. J. Med. Chem. (2021). https://doi.org/10.1021/acs.jmedchem.1c00555

34.

C.J. Aslakson, F.R. Miller, Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399–1405 (1992)PubMed

35.

C.N. Johnstone, Y.E. Smith, Y. Cao, A.D. Burrows, R.S.N. Cross, X. Ling, R.P. Redvers, J.P. Doherty, B.L. Eckhardt, A.L. Natoli, C.M. Restall, E. Lucas, H.B. Pearson, S. Deb, K.L. Britt, A. Rizzitelli, J. Li, J.H. Harmey, N. Pouliot, R.L. Anderson, Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer. Dis. Model. Mech. (2015). https://doi.org/10.1242/dmm.017830

36.

L.M. Pyter, L.P. Suarez-Kelly, W.E. Carson, J. Kaur, J. Bellisario, S.R. Bever, Novel rodent model of breast cancer survival with persistent anxiety-like behavior and inflammation. Behav. Brain. Res. (2017). https://doi.org/10.1016/j.bbr.2017.05.011

37.

D.B. Lubahn, J.S. Moyer, T.S. Golding, J.F. Couse, K.S. Korach, O. Smithies, Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA. (1993). https://doi.org/10.1073/pnas.90.23.11162

38.

S.K.Das, J.A. Taylor, K.S. Korach, B.C. Paria, K.S. Deb, D.B. Lubahn, Estrogenic responses in estrogen receptor- deficient mice reveal a distinct estrogen signaling pathway. Proc. Natl. Acad. Sci. (1997). https://doi.org/10.1073/pnas.94.24.12786

39.

P.J. Shughrue, D.B. Lubahn, A. Negro-Vilar, K.S. Korach, I. Merchenthaler, Responses in the brain of estrogen receptor α-disrupted mice. Proc. Natl. Acad. Sci. U.S.A. (1997). https://doi.org/10.1073/pnas.94.20.11008

40.

K.J. Hamilton, Y. Arao, K.S. Korach, Estrogen hormone physiology: Reproductive findings from estrogen receptor mutant mice. Reprod. Biol. (2014). https://doi.org/10.1016/j.repbio.2013.12.002

41.

P.A.S. Sheppard, E. Choleris, L.A.M. Galea, Structural plasticity of the hippocampus in response to estrogens in female rodents. Mol. Brain (2019). https://doi.org/10.1186/s13041-019-0442-7

42.

S.W. Mitra, E. Hoskin, J. Yudkovitz, L. Pear, H.A. Wilkinson, S. Hayashi, D.W. Pfaff, S. Ogawa, S.P. Rohrer, J.M. Schaeffer, B.S. McEwen, S.E. Alves, Immunolocalization of Estrogen Receptor β in the Mouse Brain: Comparison with Estrogen Receptor α. Endocrinology (2003). https://doi.org/10.1210/en.2002-221069

43.

P.G. Henke, Hippocampal pathway to the amygdala and stress ulcer development. Brain. Res. Bull. (1990). https://doi.org/10.1016/0361-9230(90)90044-Z

44.

D.S. Gross, Effect of castration and steroid replacement on immunoreactive gonadotropin-releasing hormone in the hypothalamus and preoptic area. Endocrinology (1980). https://doi.org/10.1210/endo-106-5-1442

45.

N.J. MacLusky, A.S. Clark, F. Naftolin, P.S. Goldman-Rakic, Estrogen formation in the mammalian brain: Possible role of aromatase in sexual differentiation of the hippocampus and neocortex. Steroids (1987). https://doi.org/10.1016/0039-128X(87)90032-8

46.

E. Fuente-Martin, C. Garcia-Caceres, E. Morselli, D.J. Clegg, J.A. Chowen, B. Finan, R.D. Brinton, M.H. Tschöp, Estrogen, astrocytes and the neuroendocrine control of metabolism. Rev. Endocr. Metab. Disord. (2013). https://doi.org/10.1007/s11154-013-9263-7

47.

A. Villa, E. Vegeto, A. Poletti, A. Maggi, Estrogens, Neuroinflammation, and Neurodegeneration. Endocr. Rev. (2016). https://doi.org/10.1210/er.2016-1007

48.

R.H. Straub, The complex role of estrogens in inflammation. Endocr. Rev. (2007). https://doi.org/10.1210/er.2007-0001

49.

R. Caso, R. Silvera, R. Carrio, V. Iragavarapu-Charyulu, R.R. Gonzalez-Perez, M. Torroella-Kouri, Blood monocytes from mammary tumor-bearing mice: Early targets of tumor-induced immune suppression? Int. J. Oncol. (2010). https://doi.org/10.3892/ijo_00000740

50.

E.J. Kovacs, T.P. Plackett, P.L. Witte, Estrogen replacement, aging, and cell-mediated immunity after injury. J. Leukoc. Biol. (2004). https://doi.org/10.1189/jlb.1103538

51.

H.J. Son, S.H. Sohn, N. Kim, H.-N. Lee, S.M. Lee, R.H. Nam, J.H. Park, C.-H. Song, E. Shin, H.Y. Na, J.S. Kim, D.H. Lee, Y.-J. Surh, Effect of Estradiol in an Azoxymethane/Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development. Cancer Res. Treat. (2019). https://doi.org/10.4143/crt.2018.060

52.

E.T. Fantozzi, A.C. Breithaupt-Faloppa, F.Y. Ricardo-da-Silva, S. Rodrigues-Garbin, D.C. Romero, A. da Silva Rodrigues, Y. Riffo-Vasquez, W. Taveres-de-Lima, Estradiol mediates the long-lasting lung inflammation induced by intestinal ischemia and reperfusion. J. Surg. Res. (2018). https://doi.org/10.1016/j.jss.2017.07.038

53.

M. Yang, J. Kim, J.-S. Kim, S.-H. Kim, J.-C. Kim, M.-J. Kang, U. Jung, T. Shin, H. Wang, C. Moon, Hippocampal dysfunctions in tumor-bearing mice. Brain Behav. Immun. (2014). https://doi.org/10.1016/j.bbi.2013.10.022

54.

A.J. Bruce-Keller, J.L. Keeling, J.N. Keller, F.F. Huang, S. Camondola, M.P. Mattson, Antiinflammatory Effects of Estrogen on Microglial Activation. Endocrinology (2000). https://doi.org/10.1210/endo.141.10.7693

55.

Y. Xu, H. Sheng, Z. Tang, J. Lu, X. Ni, Inflammation and increased IDO in hippocampus contribute to depression-like behavior induced by estrogen deficiency. Behav. Brain Res. (2015). https://doi.org/10.1016/j.bbr.2015.04.017

56.

Z. Tian, J. Fan, Y. Zhao, S. Bi, L. Si, Q. Liu, Estrogen receptor beta treats Alzheimer’s disease. Neural Regen. Res. (2013). https://doi.org/10.3969/j.issn.1673-5374.2013.05.005

57.

K.G. Vargas, J. Milic, A. Zaciragic, K.-X. Wen, L. Jaspers, J. Nano, K. Dhana, W.M. Bramer, B. Kraja, E. van Beeck, M.A. Ikram, T. Muka, O.H. Franco, The functions of estrogen receptor beta in the female brain: a systematic review. Maturitas (2016). https://doi.org/10.1016/j.maturitas.2016.05.014

58.

V.L. Nordell, M.M. Scarborough, A.K. Buchanan, F. Sohrabji, Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. Neurobiol. Aging (2003). https://doi.org/10.1016/S0197-4580(02)00193-8

59.

J.C. Santos, S.R. Bever, G. Pereira-da-Silva, L.M. Pyter, Tumor resection ameliorates tumor-induced suppression of neuroinflammatory and behavioral responses to an immune challenge in a cancer survivor model. Sci. Rep. (2019). https://doi.org/10.1038/s41598-018-37334-8

60.

E. Ogura, K. Kageyama, K. Hanada, J. Kasckow, T. Suda, Effects of estradiol on regulation of corticotropin-releasing factor gene and interleukin-6 production via estrogen receptor type β in hypothalamic 4B cells. Peptides (2008). https://doi.org/10.1016/j.peptides.2007.11.007

Titel: A novel targeted approach to delineate a role for estrogen receptor-β in ameliorating murine mammary tumor-associated neuroinflammation
verfasst von: Corena V. Grant
Kathryn L. G. Russart
Leah M. Pyter
Publikationsdatum: 19.11.2021
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2022
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-021-02931-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Bildnachweise

Die Leitlinien für Ärztinnen und Ärzte, Digitale Mammographien links in kraniokaudaler Projektion./© Weigel, S. et al. / all rights reserved Springer Medizin Verlag GmbH, Operation bei Blasenkrebs/© anistidesign / Fotolia, Medizinische Fachangestellte sitzt erschöpft auf der Treppe/© Courtney Haas / peopleimages.com /stock.adobe.com (Symbolbild mit Fotomodell), Mann wird von Ärztin untersucht/© Tashi-Delek, Getty Images, iStock (Symbolbild mit Fotomodellen)

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres

Thyroid disorders and cardiovascular manifestations: an update

Association between metabolic syndrome and clinicopathological features of papillary thyroid cancer

Efficacy and safety of once-weekly semaglutide in adults with overweight or obesity: a meta-analysis

Endoscopic transsphenoidal surgery for biochemically and clinically non-functioning adenohypophyseal tumours in the elderly: experience from a single UK centre